Prev：Rationally Engineered Adenosine A2A Decoy Receptor for Reversing Immunosuppression of Breast Cancer(KTA1001-12.1)
Next：Received 10 July 2024; received in revised form 15 September 2024; accepted 26 November 2024* Corresponding authors. E-mail addresses: zhiping0414 …(A23210-)
